LSL Pharma Group Inc (LSL-DB.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:LSL-DB -
LSL-DB.CA Key Statistics, Chart & Performance
The current stock price of LSL-DB.CA is 100 CAD.
LSL-DB.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| JWEL.CA | JAMIESON WELLNESS INC | 19.23 | 1.41B | ||
| LOVE.CA | CANNARA BIOTECH INC | 12.43 | 165.13M | ||
| GENX.CA | GENIX PHARMACEUTICALS CORP | N/A | 1.53M |
Related stock screener links
About LSL-DB.CA
Company Profile
LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. The company specializes in the manufacturing and marketing of natural health products (NHPs). The firm manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The firm also owns Dermolab Pharma Ltd., a contract manufacturing company that specializes in the development, manufacturing and packaging of liquid and semi-solid cosmetic, pharmaceutical and natural health products. The company serves both the Canadian and international markets. The firm's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Virage Sante Inc.
Company Info
LSL Pharma Group Inc
540, rue d'Avaugour, Office 1800
Boucherville QUEBEC CA
Employees: 114
Phone: 14506817744
LSL Pharma Group Inc / LSL-DB.CA FAQ
What does LSL Pharma Group Inc do?
LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. The company specializes in the manufacturing and marketing of natural health products (NHPs). The firm manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The firm also owns Dermolab Pharma Ltd., a contract manufacturing company that specializes in the development, manufacturing and packaging of liquid and semi-solid cosmetic, pharmaceutical and natural health products. The company serves both the Canadian and international markets. The firm's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Virage Sante Inc.
Can you provide the latest stock price for LSL Pharma Group Inc?
The current stock price of LSL-DB.CA is 100 CAD.
Does LSL Pharma Group Inc pay dividends?
LSL-DB.CA does not pay a dividend.
What is the ChartMill rating of LSL Pharma Group Inc stock?
LSL-DB.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for LSL Pharma Group Inc?
LSL Pharma Group Inc (LSL-DB.CA) operates in the Consumer Staples sector and the Personal Care Products industry.
How is the valuation of LSL Pharma Group Inc (LSL-DB.CA) based on its PE ratio?
LSL Pharma Group Inc (LSL-DB.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
How many employees does LSL Pharma Group Inc have?
LSL Pharma Group Inc (LSL-DB.CA) currently has 114 employees.
LSL-DB.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to LSL-DB.CA.
LSL-DB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LSL-DB.CA. Both the profitability and financial health of LSL-DB.CA have multiple concerns.
LSL-DB.CA Financial Highlights
Over the last trailing twelve months LSL-DB.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -17.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.37% | ||
| ROE | -8.14% | ||
| Debt/Equity | 0.45 |